Meet our team




SynexusPlusSite network optimizationPatient engagement strategySuccessful start upRecruitment and retentionPatient communitiesOptimizing trial quality

By submitting your details, you consent to their use in accordance with our Privacy Policy

Come and see us at Booth #2115

Synexus are attending the DIA 2018 Global Annual Meeting in Boston, Massachusetts, 24 – 28 June. Our Business Development team will be available at the booth to discuss how the Synexus model delivers the right patients at the right time for the right trial. Please complete the form above or contact us to arrange a personal demonstration.

DIA, founded as the Drug Information Association, has provided a global, yet neutral stage, for collaboration to address healthcare challenges for more than 50 years. DIA’s Global Annual Meeting (DIA 2018) gathers stakeholders from across the world to openly knowledge share, generating insights beyond boundaries to advance innovation in healthcare product development and lifecycle management globally.

As the largest, longest-running event in the life sciences industry, this gathering is designed to foster the international exchange of actionable insights to improve health globally through the advancement of lifesaving medicines and technologies. DIA 2018 Global Annual Meeting will host more than 6,000 professionals in the pharmaceutical, biotechnology and medical device communities from more than 50 countries around the globe and 450+ exhibiting companies.

SynexusPlus

We are excited to introduce SynexusPlus, the new standard in clinical trial productivity. Being the largest global site network, combined with hyper-efficient patient enrolment enables us to provide this unique only turnkey, results-based, record-breaking product.

Enrolment certainty

Increased trial productivity for any strategic need

  • Recruitment rates more than double the industry average
  • Up to 4X faster site start-up times
  • 30%-50% faster enrolment
  • 30%-50% fewer sites
  • Up to 80% of patients provided for chronic ambulatory trials
  • High-quality patients and minimized patient attrition
Budget certainty

Results-based commercial terms for peace of mind

  • All site and enrolment fees rolled into one price per patient, including investigator grants, procedural fees, and recruiting fees
  • Capped budgets with the potential for bonus/penalty terms
  • Simplified and centralized contracting across all sites to increase speed of study start-up and maximize site footprint from day one

Come and see us at Booth #2115 to discover how SynexusPlus can optimise productivity and efficiency.

Synexus: The largest global network of clinical research sites

We select the lowest number of sites needed from the network to meet your overall enrolment goal. You can add KOLs and other sites as desired.

+
Acurian: The world-class provider of patient enrolment

A diverse team of full-time specialists leverages proprietary, fully-identified patient data to deliver large volumes of pre-qualified patients who live near, but are unknown to, the sites.

= SynexusPlus